NCT05632978 An Observational Study of Epilepsy: Biology and Outcomes Using Real-world Data
| NCT ID | NCT05632978 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Cardiff and Vale University Health Board |
| Condition | Epilepsy |
| Study Type | OBSERVATIONAL |
| Enrollment | 2,000 participants |
| Start Date | 2023-04-24 |
| Primary Completion | 2032-12 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 2,000 participants in total. It began in 2023-04-24 with a primary completion date of 2032-12.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The goal of this observational study is to learn more about phenotypic, genetic, biochemical, neurophysiological and radiological patterns in epilepsy. Participants will be asked to consent to use of clinical and paraclinical data (obtained during standard care) for research, and will be asked to donate blood samples at their routine clinic visits.
Eligibility Criteria
Inclusion Criteria: * Individual is being investigated for epilepsy and under the clinical care of the epilepsy unit at Cardiff \& Vale University Health Board or regional clinics in Cwm Taf. * Individual is at least 16 years old. * Informed consent sought and given by individual. Exclusion Criteria: * None
Contact & Investigator
Khalid Hamandi
PRINCIPAL INVESTIGATOR
Cardiff & Vale University Health Board
Frequently Asked Questions
Who can join the NCT05632978 clinical trial?
This trial is open to participants of all sexes, aged 16 Years or older, studying Epilepsy. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05632978 currently recruiting?
Yes, NCT05632978 is actively recruiting participants. Contact the research team at khalid.hamandi@wales.nhs.uk for enrollment information.
Where is the NCT05632978 trial being conducted?
This trial is being conducted at Cardiff, United Kingdom.
Who is sponsoring the NCT05632978 clinical trial?
NCT05632978 is sponsored by Cardiff and Vale University Health Board. The principal investigator is Khalid Hamandi at Cardiff & Vale University Health Board. The trial plans to enroll 2,000 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.